Razavi HA

August 10, 2020
Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models
Summary Hepatitis B is a global epidemic that requires carefully orchestrated vaccination initiatives in geographical regions of medium to high endemicity to reach the World Health Organization’s elimination targets by 2030. This study compares two widely-used deterministic hepatitis B models—the Imperial HBV model and the CDA Foundation’s PRoGReSs—based on their predicted outcomes in four countries. […]

Read More
August 7, 2020
Impact of COVID-19 on global HCV elimination efforts
Summary Background & Aims Coronavirus disease 2019 (COVID-19) has placed a significant strain on national healthcare systems at a critical moment in the context of hepatitis elimination. Mathematical models can be used to evaluate the possible impact of programmatic delays on hepatitis disease burden. The objective of this analysis was to evaluate the incremental change […]

Read More
July 28, 2020
The Hep-CORE policy score: A European hepatitis C national policy implementation ranking based on patient organization data
Summary Background New hepatitis C virus (HCV) treatments spurred the World Health Organization (WHO) in 2016 to adopt a strategy to eliminate HCV as a public health threat by 2030. To achieve this, key policies must be implemented. In the absence of monitoring mechanisms, this study aims to assess the extent of policy implementation from […]

Read More
July 27, 2020
Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?
Summary Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C? In 2019, a Lancet Gastroenterology & Hepatology Commission on accelerating the elimination of viral hepatitis reported on the status of 11 viral hepatitis policy indicators in 66 countries and territories with the heaviest burden by global region. […]

Read More
July 12, 2020
Tailored screening and dedicated funding for direct acting antiviral drugs: how to keep Italy on the road to hepatitis C virus elimination?
Summary Background and aims Hepatitis C virus (HCV) elimination for Italy is an ambitious, but achievable goal. In Italy, there is political will, which aims to achieve the World Health Organization (WHO) elimination goals recognizing the need to identify undiagnosed individuals in key high-risk groups and in the general population, however there is concern regarding […]

Read More
June 13, 2020
Editorial: increasing burden of nonalcoholic fatty liver disease-a call to action. Authors’ reply
Summary No abstract available. Countries: Singapore, South Korea

Read More
June 12, 2020
Global Epidemiology of Viral Hepatitis
Summary Viral hepatitis (hepatitis A, B, C, D, and E) is the leading cause of inflammation of liver tissue (hepatitis). The disease burden associated with hepatitis A and E occurs shortly after infection, and it is more severe among adults. With hepatitis A and E, the number of incident cases (new acute infections) is important […]

Read More
June 9, 2020
Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study
Summary Background Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) account for a growing proportion of liver disease cases, and there is a need to better understand future disease burden. We used a modelling framework to forecast the burden of disease of NAFLD and NASH for Canada. Methods We used a Markov model to […]

Read More
May 1, 2020
Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated Model
Summary Importance Achievement of the World Health Organization (WHO) target of eliminating hepatitis C virus (HCV) by 2030 will require an increase in key services, including harm reduction, HCV screening, and HCV treatment initiatives in member countries. These data are not available for Canada but are important for informing a national HCV elimination strategy. Objective […]

Read More
April 28, 2020
A tool to measure the impact of inaction toward elimination of hepatitis C: A case study in Korea
Summary Background and aims Hepatitis C virus (HCV) and its sequelae present a significant source of economic and societal burden. Introduction of highly effective curative therapies has made HCV elimination attainable. The study used a predictive model to assess the clinical and economic impact of implementing national screening and treatment policies toward HCV elimination in […]

Read More

CDAF

Polaris

Grants

Partnerships

Publications

Tools

Razavi HA

Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models

Impact of COVID-19 on global HCV elimination efforts

The Hep-CORE policy score: A European hepatitis C national policy implementation ranking based on patient organization data

Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?

Tailored screening and dedicated funding for direct acting antiviral drugs: how to keep Italy on the road to hepatitis C virus elimination?

Editorial: increasing burden of nonalcoholic fatty liver disease-a call to action. Authors’ reply

Global Epidemiology of Viral Hepatitis

Burden of nonalcoholic fatty liver disease in Canada, 2019-2030: a modelling study

Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated Model

A tool to measure the impact of inaction toward elimination of hepatitis C: A case study in Korea

Useful Links, CDAF

Useful Links, Polaris

Latest News

Best Practices to Reengage Lost Hep B Patients: Helen Nde, MPH

Report: Hepatitis B Vaccine Safe; Delaying Would Lead to Increased Infections